Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
Enrolling by invitation · Not applicable
Conditions studied: Metabolic-dysfunction Associated Liver Disease (MASLD)
In brief
The purpose of this study is to understand if a behavioral lifestyle intervention called the Healthy Liver/Hígado Sano program can help Hispanic/Latino patients with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease (NAFLD), lose weight and improve their liver health
Key facts
- Study ID
- NCT07199491
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 64
- Starts
- 2026-01-29
- Expected to finish
- 2027-10-31
- Last updated by the study team
- 2026-03-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Self-reported Hispanic/Latino
- Have been diagnosed with MASLD
- Be an adult >= 18 years of age
- Able to speak English or Spanish
- Have a working telephone number
- Have access to internet, either on their phone, at home or at some other location convenient to the participant
- Have a family member willing to attend all sessions
You may not qualify if…
- Taking a GLP-1 receptor agonist or dual agonist at the time of enrollment, or plans to being taking one in the next 6 months
Where it is running
- The University of Texas Health Science Center at Houston — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.